{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:21:30Z","timestamp":1754151690945,"version":"3.41.2"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ajoc.2022.101771","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T02:50:15Z","timestamp":1670208615000},"page":"101771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Type 3 macular neovascularization in a patient with pentosan polysulfate maculopathy"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5926-1385","authenticated-orcid":false,"given":"Elodie","family":"Bousquet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8515-345X","authenticated-orcid":false,"given":"Brian A.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9578-6362","authenticated-orcid":false,"given":"Ahmad","family":"Santina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4939-3306","authenticated-orcid":false,"given":"SriniVas","family":"Sadda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Sarraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ajoc.2022.101771_bib1","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.ophtha.2018.04.026","article-title":"Pigmentary maculopathy associated with chronic exposure to pentosan polysulfate sodium","volume":"125","author":"Pearce","year":"2018","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajoc.2022.101771_bib2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jcjo.2019.12.001","article-title":"Pentosan-associated maculopathy: prevalence, screening guidelines, and spectrum of findings based on prospective multimodal analysis","volume":"55","author":"Wang","year":"2020","journal-title":"Can J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2022.101771_bib3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.survophthal.2021.05.005","article-title":"Pentosan polysulfate maculopathy","volume":"67","author":"Lindeke-Myers","year":"2022","journal-title":"Surv Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajoc.2022.101771_bib4","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1001\/jamaophthalmol.2020.2349","article-title":"Disease course in patients with pentosan polysulfate sodium-associated maculopathy after drug cessation","volume":"138","author":"Shah","year":"2020","journal-title":"JAMA Ophthalmol."},{"issue":"11","key":"10.1016\/j.ajoc.2022.101771_bib5","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jamaophthalmol.2019.3392","article-title":"Phenotypic spectrum of pentosan polysulfate sodium-associated maculopathy: a multicenter study","volume":"137","author":"Hanif","year":"2019","journal-title":"JAMA Ophthalmol."},{"issue":"1","key":"10.1016\/j.ajoc.2022.101771_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.oret.2019.08.006","article-title":"Choroidal neovascularization associated with pentosan polysulfate toxicity","volume":"4","author":"Mishra","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.ajoc.2022.101771_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ajo.2021.02.025","article-title":"Pentosan polysulfate maculopathy: prevalence, spectrum of disease, and choroidal imaging analysis based on prospective screening","volume":"227","author":"Wang","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajoc.2022.101771_bib8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/IAE.0b013e3181669504","article-title":"Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation","volume":"28","author":"Freund","year":"2008","journal-title":"Retina"},{"issue":"Suppl 1","key":"10.1016\/j.ajoc.2022.101771_bib9","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1097\/IAE.0000000000001268","article-title":"AN updated staging system of type 3 neovascularization using spectral domain optical coherence tomography","volume":"36","author":"Su","year":"2016","journal-title":"Retina"},{"issue":"11","key":"10.1016\/j.ajoc.2022.101771_bib10","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1097\/IAE.0000000000000835","article-title":"Optical coherence tomography angiography of type 3 neovascularization secondary to age-related macular degeneration","volume":"35","author":"Kuehlewein","year":"2015","journal-title":"Retina"},{"issue":"5","key":"10.1016\/j.ajoc.2022.101771_bib11","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/bjophthalmol-2016-308815","article-title":"Optical coherence tomography angiography of type 3 neovascularisation in age-related macular degeneration after antiangiogenic therapy","volume":"101","author":"Phasukkijwatana","year":"2017","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2022.101771_bib12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000471790","article-title":"Type 3 neovascularization associated with retinitis pigmentosa","volume":"8","author":"Sayadi","year":"2017","journal-title":"Case Rep. Ophthalmol."},{"issue":"6","key":"10.1016\/j.ajoc.2022.101771_bib13","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/ICB.0000000000000892","article-title":"Multimodal evidence of type 3 neovascularization in enhanced S-cone syndrome","volume":"15","author":"Maldonado","year":"2021","journal-title":"Retin Cases Brief Rep"},{"issue":"2","key":"10.1016\/j.ajoc.2022.101771_bib14","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ophtha.2017.08.019","article-title":"Clinicopathologic correlation of anti-vascular endothelial growth factor-treated type 3 neovascularization in age-related macular degeneration","volume":"125","author":"Li","year":"2018","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.ajoc.2022.101771_bib15","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.oret.2018.04.016","article-title":"Nascent type 3 neovascularization in age-related macular degeneration","volume":"2","author":"Sacconi","year":"2018","journal-title":"Ophthalmol Retina"},{"issue":"10","key":"10.1016\/j.ajoc.2022.101771_bib16","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1097\/IAE.0000000000002198","article-title":"Reduced choriocapillaris flow in eyes with type 3 neovascularization and age-related macular degeneration","volume":"38","author":"Borrelli","year":"2018","journal-title":"Retina"},{"issue":"9","key":"10.1016\/j.ajoc.2022.101771_bib17","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1097\/IAE.0000000000003119","article-title":"Choriocapillaris flow impairment in type 3 macular neovascularization: a quantitative analysis using swept-source optical coherence tomography angiography","volume":"41","author":"Le","year":"2021","journal-title":"Retina"},{"issue":"7","key":"10.1016\/j.ajoc.2022.101771_bib18","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1007\/s00417-020-05056-1","article-title":"Quantitative assessment of choriocapillaris flow deficits in eyes with macular neovascularization","volume":"259","author":"Corvi","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajoc.2022.101771_bib19","doi-asserted-by":"crossref","unstructured":"Levin MF, Santina A, Corradetti G, et al. Pentosan polysulfate sodium-associated maculopathy: early detection using OCT angiography and choriocapillaris flow deficit analysis. Am J Ophthalmol. Published online July 25, 2022:S0002-9394(22)00284-7. doi:10.1016\/j.ajo.2022.07.015.","DOI":"10.1016\/j.ajo.2022.07.015"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993622005175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993622005175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T03:06:42Z","timestamp":1752980802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993622005175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":19,"alternative-id":["S2451993622005175"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2022.101771","relation":{},"ISSN":["2451-9936"],"issn-type":[{"type":"print","value":"2451-9936"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 3 macular neovascularization in a patient with pentosan polysulfate maculopathy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2022.101771","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101771"}}